Fraxel® Dual Laser System Receives New FDA 510(k) Clearance For Treatment Of Skin Pigmentation

Solta Medical, Inc. (Nasdaq:SLTM), the global market leader in aesthetic skin treatments, today announced it has received a new FDA 510(k) clearance of its Fraxel® DUAL 1550/1927 laser system for the treatment of pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots) and ephelides (freckles)
Source: Medical Design Online News - Category: Medical Equipment Source Type: news